HemosIL SynthAFax. Partial Thromboplastin Time Tests. Recall
HemosIL SynthAFax. Partial Thromboplastin Time Tests.
FDA recall Class III
Ongoing
FDA lists this Class III recall for HemosIL SynthAFax. Partial Thromboplastin Time Tests.. Review the affected identifiers, reported reason and manufacturer instructions below.
Recall at a glance
- Recall number
- Z-0938-2026
- Recall classification
- Class III
- Enforcement status
- Ongoing
- Initiation date
- Nov 18, 2025
- FDA report date
- Dec 24, 2025
- Quantity in commerce
- 4,506 units
- Distribution
- See key details
- FDA cause
- Process control
What is being recalled?
HemosIL SynthAFax. Partial Thromboplastin Time Tests.
Affected model & UDI checker
Search the exact identifiers published for Z-0938-2026.
The lookup covers structured identifiers listed on this page. A full UDI may also contain lot or serial information; a GTIN match alone does not check those conditions.
Affected products
| Model / catalog number | Product | Lot scope reported | UDI / GTIN |
|---|---|---|---|
| Not specified | HemosIL SynthAFax. Partial Thromboplastin Time Tests. | Check source notice | 08426950087649 |
FDA code information
Part No. 0020007400; UDI: 08426950087649; Lot No. (Exp. Date) N0542231(2026-06-30), N0250088(2027-04-30, N0452249 (2027-06-30).
Why was this product recalled?
Recalled lots were manufactured with double the amount of preservative concentration.
What actions did Instrumentation Laboratory take?
An URGENT MEDICAL DEVICE RECALL notification, dated 11/18/25, was sent to consignees. Consignees are to contact Client Services at 1-800-955-9525 to arrange conversion to replacement lot N0956748, and in the meantime continue use of affected lots with the QC lot reassignments provided and run QC per labeled instructions for use. Once the replacement lot is received, consignees are to complete the cross-over study per laboratory procedures and immediately destroy affected devices, documenting destruction on the provided Mandatory Urgent Medical Device Recall Tracking Form which should be returned to WERFEN by fax at 781-861-4207 or by email to ra-usa.na@werfen.com. All laboratory staff are to be notified of this recall and a copy of the notice posted near IL Coagulation Systems. Consignees with any questions are to contact Client Services at 1-800-955-9525.
Read the manufacturer action recorded by FDARecall timeline
Recall initiated by firm
FDA notice posted
FDA classification recorded
FDA enforcement report date
Related FDA submissions
No submission number with an exact verified relationship is linked in the retrieved recall notice.
FDA’s notice explicitly links the submission numbers shown here. Read each filing for its own recorded device and scope.
Source and update history
- FDA recall notice Z-0938-2026
- openFDA enforcement record · Source release Nov 11, 2026 · Retrieved Nov 21, 2026
- openFDA device recall record · Source release Nov 19, 2026 · Retrieved Nov 21, 2026
- FDA enforcement data
First stored snapshot of this source.
- FDA device-recall notice
First stored snapshot of this source.
The history starts with the versions held by MedtechLedger. Earlier source changes are not reconstructed. Official dates and recorded status come from FDA; page summaries describe the source information.
Our data sources and methodology